Bloomberg News

Galenica, Fresenius Joint Venture Gets Antitrust Approval

October 06, 2011

Oct. 6 (Bloomberg) -- Galenica AG said its joint venture with Fresenius Medical Care AG & Co, Vifor Fresenius Medical Care Renal Pharma Ltd., got Swiss and European antitrust approval and will proceed with the targeted expansion of its operation in Europe and other countries after the formal closing in November, 2011.

To contact the editor responsible for this story: Paul Verschuur at pverschuur@bloomberg.net


Burger King's Young Buns
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus